Herbal supplement fails to show clear benefit in optic neuritis pilot
NCT ID NCT02976766
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study tested whether adding gypenosides (a herbal supplement) to standard steroid treatment could help protect the nerve at the back of the eye in adults having their first episode of acute optic neuritis. Ten participants were enrolled, but the study was stopped early. The main goal was to measure nerve thickness in the affected eye after six months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEURITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New MRI techniques could sharpen diagnosis of optic nerve inflammation
- Genetic clues may forecast multiple sclerosis after vision loss
- New eye test criteria could speed up diagnosis of vision loss cause
- New drug aims to save sight in optic neuritis patients
- Eye camera spots hidden inflammation in MS patients
- Can a common antihistamine help heal the optic nerve?